Psychiatry and Neurology, Neurology · Ottawa, KS
NPI
1265551873
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1301 S Main St
Ottawa, KS, 66067
Phone (785) 242-4003
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
180 services
Medicare patients, 2024
116
Average age 77
Drug cost, 2024
$2.0M
12,686 prescriptions
Company payments, 2025
$1,784
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farhan A Sheikh was code 99222 (hospital e&m - initial), 75 times for 71 patients. In total Farhan A Sheikh billed 180 services in 11 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99222 Hospital E&M - Initial | Facility | 75 | 71 | $80.24 | $6,018 |
| 95819 Neurologic | Facility | 26 | 26 | $41.17 | $1,071 |
| 99232 Hospital E&M - Subsequent | Facility | 26 | 22 | $50.83 | $1,322 |
| 95886 Electrical Nerve Conductivity | Office | 17 | 12 | $90.28 | $1,535 |
By year: 2022 $6,678 for 112 services; 2023 $8,886 for 129 services; 2024 $13K for 180 services.
Medicare prescription drug claims, 2024
In 2024, the drug Farhan A Sheikh prescribed most often to Medicare patients was Gabapentin, with 1,496 prescriptions and refills. In total Farhan A Sheikh wrote 12,686 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,496 | 1,937 | 294 | $22K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,054 | 1,391 | 179 | $28K |
| Memantine Hcl Generic | 944 | 1,377 | 181 | $29K |
| Donepezil Hcl Generic | 881 | 1,292 | 166 | $6,054 |
| Pregabalin Generic | 559 | 635 | 95 | $14K |
| Primidone Generic | 499 | 748 | 89 | $13K |
| Duloxetine Hcl Generic | 491 | 598 | 102 | $8,455 |
| Nortriptyline Hcl Generic | 449 | 567 | 79 | $3,606 |
| Levetiracetam Generic | 381 | 501 | 61 | $11K |
| Tizanidine Hcl Generic | 374 | 506 | 91 | $2,117 |
| Ropinirole Hcl Generic | 366 | 586 | 74 | $8,514 |
| Oxcarbazepine Generic | 347 | 431 | 54 | $24K |
| Propranolol Hcl Generic | 310 | 400 | 57 | $4,245 |
| Topiramate Generic | 268 | 337 | 49 | $2,151 |
| Amitriptyline Hcl Generic | 253 | 349 | 47 | $2,378 |
Brand drugs: 582 claims; generic drugs: 12,104 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farhan A Sheikh $1,784 ($1,784 in general payments such as food, travel and fees) from 36 companies. The largest payer was Abbvie Inc. with $221.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 28 | $221 |
| Neurocrine BioSciences, Inc. NBIX | 13 | $152 |
| Teva Pharmaceuticals USA, Inc. TEVA | 8 | $135 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $93.92 |
| UCB, Inc. UCB.BR | 3 | $69.76 |
| Genentech USA, Inc. ROG.SW | 3 | $68.68 |
| Argenx US, Inc. ARGX | 3 | $65.28 |
| Pfizer Inc. PFE | 4 | $64.62 |
| Lundbeck LLC | 3 | $61.8 |
| SK Life Science, Inc. | 3 | $61.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.